Tony Chung – CEO & Co-Founder, Instant NanoBiosensors, Taiwan

Tony Chung, CEO of Instant NanoBiosensors explains the potential of their fibre-optic biosensor technology – FOPPR, and the commercialization strategy for their light-sensing biomarker analyzer INB-D200. He also highlights Taiwan’s strengths in developing value-added biomedical technology.  
With the trend of precision medicine growing, innovative devices are needed to help monitor patients
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Already a member? Sign In

Related Interviews

Latest Report